Abstract
Background
Drug interactions in the neurosciences intensive care unit (NICU) may involve antiepileptic drugs and warfarin. Most commonly used antiepileptic drugs are either potent hepatic enzyme inducers or inhibitors and they affect the metabolism of warfarin. Valproic acid also displaces warfarin from the protein binding sites resulting in significant INR changes but this type of drug interaction is less well known.
Methods
Case report.
Results
A 71 year-old female patient with a glioblastoma multiforme presented to the NICU with refractory partial complex seizures. Patient was on warfarin for a prior deep venous thrombosis. After treatment with levetiracetam, seizures recurred and intravenous loading with valproic acid was administered, but resulted in a rapid increase in international normalized ratio (INR) to 7.6. A MRI of the brain showed hemorrhagic tumor, but no new major bleeding.
Conclusions
With both acidic drugs present, a loading dose of valproic acid may displace warfarin from the protein binding sites resulting in redistribution of warfarin in free active form and lead to a rapid increase in INR.
References
McQueen EQ, Wardell WM. Drug displacement from protein binding: isolation of a redistribution drug interaction in vivo. Br J Pharm. 1971;43:312–24.
Gail D, Anderson A. Mechanistic approach to antiepileptic drug interactions. Ann Pharmacother. 1998;32:554–63.
Ahmed SN. Antiepileptic drugs and warfarin. CMAJ. 2008;178:65.
Patasalos PN, Perucca E. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol. 2003;2:473–81.
Micromedex® Healthcare series, valproic acid and warfarin pharmacokinetics.
Seller EM, Koch-Weser J. Kinetics and clinical importance of displacement of warfarin from albumin by acidic drugs. Ann N Y Acad Sci. 1971;170:213–25.
Guthrie SK, Anne M, Bader G, Hilleman D. Hypothesized interaction between valproic acid and warfarin. J Clin Psychopharm. 1995;15:138–9.
Bailey DN, Briggs JR. The binding of acetaminophen, lidocaine, and valproic acid to human milk. Am J Clin Pathol. 2004;121:754–7.
Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs. 2002;16:695–714.
Kaminsky LS, Zhang ZY. Human P450 metabolism of warfarin. Pharmacol Ther. 1997;73:67–74.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoon, H.W., Giraldo, E.A. & Wijdicks, E.F.M. Valproic Acid and Warfarin: An Underrecognized Drug Interaction. Neurocrit Care 15, 182–185 (2011). https://doi.org/10.1007/s12028-011-9544-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-011-9544-5